Completed PHASE4 INTERVENTIONAL 2-arm NCT01693003

Indacaterol Versus Tiotropium on Dynamic Hyperinflation in COPD

Randomized, Open-label, Crossover Clinical Trial to Assess the Effects of Indacaterol 150 µg d.o. Compared to Tiotropium Bromide 5 µg d.o. on Dyspnea, Dynamic Pulmonary Hyperinflation and Exercise Tolerance in Patients With Moderate COPD

Sponsor: Irmandade Santa Casa de Misericórdia de Porto Alegre

Conditions Chronic Obstructive Pulmonary Disease

Interventions Indacaterol Tiotropium

Updated 5 times since 2017 Last updated: Jan 6, 2014 Started: Mar 31, 2013 Primary completion: Oct 31, 2013 Completion: Oct 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Chronic Obstructive Pulmonary Disease, this trial is completed. The trial is conducted by Irmandade Santa Casa de Misericórdia de Porto Alegre and has accumulated 5 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Mar 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Irmandade Santa Casa de Misericórdia de Porto Alegre
Novartis

Data source: Irmandade Santa Casa de Misericórdia de Porto Alegre

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Porto Alegre, Brazil